| 1 | Primary amyloidosis | 37.6% |
| 2 | Leukemia, Plasma Cell | 35.5% |
| 3 | Lymphoma | 31.1% |
| 4 | Multiple Myeloma | 28.1% |
| 5 | Composite Lymphoma | 24.7% |
| 6 | Tumor Lysis Syndrome | 23.3% |
| 7 | Sezary Syndrome | 23% |
| 8 | Hodgkin Disease | 21.7% |
| 9 | Lymphoma, Non-Hodgkin | 21.7% |
| 10 | Lymphangioleiomyomatosis | 21.2% |
| 11 | leukemia | 20.5% |
| 12 | Neoplasms, Germ Cell and Embryonal | 20.5% |
| 13 | Neoplasms, Glandular and Epithelial | 20.5% |
| 14 | Germ Cell Cancer | 20.5% |
| 15 | Neuroectodermal Tumors | 20% |
| 16 | Neoplasms, Neuroepithelial | 19.7% |
| 17 | Gliomatosis cerebri | 19.7% |
| 18 | Leukemia, T-Cell | 19.6% |
| 19 | Leukemia, B-Cell | 19.6% |
| 20 | Autoimmune Lymphoproliferative Syndrome | 19.3% |
| 21 | melanoma | 17.6% |
| 22 | Carcinosarcoma | 17.4% |
| 23 | Hemangiosarcoma | 17.4% |
| 24 | lymphangiosarcoma | 17.4% |
| 25 | Lymphoma, Follicular | 17.2% |
| 26 | T-Cell Lymphoma | 17.2% |
| 27 | Mantle cell lymphoma | 17.2% |
| 28 | Medulloblastoma | 16.8% |
| 29 | Waldenstrom Macroglobulinemia | 16.5% |
| 30 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 16.2% |
| 31 | Leukemia, Large Granular Lymphocytic | 16.2% |
| 32 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 16.2% |
| 33 | Lymphomatoid Granulomatosis | 16% |
| 34 | Adenoma, Acidophil | 15.6% |
| 35 | Ganglioneuroma | 15.6% |
| 36 | Glioma | 15.6% |
| 37 | Malignant Glioma | 15.6% |
| 38 | Infectious Mononucleosis | 15.5% |
| 39 | Histiocytic Disorders, Malignant | 15.3% |
| 40 | Paraproteinemias | 15.3% |
| 41 | Lymphoma, T-Cell, Cutaneous | 15% |
| 42 | Lymphoma, AIDS-Related | 15% |
| 43 | Enteropathy-Associated T-Cell Lymphoma | 15% |
| 44 | Primary Effusion Lymphoma | 15% |
| 45 | Carcinoma 256, Walker | 15% |
| 46 | Basal cell carcinoma | 14.8% |
| 47 | Carcinoma, Papillary | 14.8% |
| 48 | Squamous cell carcinoma | 14.8% |
| 49 | Chondrosarcoma | 14.8% |
| 50 | Craniopharyngioma | 14.8% |
| 51 | Cystadenoma | 14.8% |
| 52 | leiomyosarcoma | 14.8% |
| 53 | liposarcoma | 14.8% |
| 54 | Mesothelioma | 14.8% |
| 55 | synovial sarcoma | 14.8% |
| 56 | Neuroectodermal Tumor, Melanotic | 14.8% |
| 57 | Angiomyolipoma | 14.8% |
| 58 | Clear Cell Sarcoma of Soft Tissue | 14.8% |
| 59 | Alveolar Soft Part Sarcoma | 14.8% |
| 60 | Neuroendocrine Tumors | 14.8% |
| 61 | Sarcoma, Myeloid | 14.8% |
| 62 | Carcinoma, Basal Cell | 14.8% |
| 63 | Carcinoid Tumor | 14.6% |
| 64 | Neurilemmoma | 14.6% |
| 65 | Hutchinson's Melanotic Freckle | 14.6% |
| 66 | Melanoma, Amelanotic | 14.6% |
| 67 | Meningioma | 14.5% |
| 68 | Mycosis Fungoides | 13.9% |
| 69 | Lymphomatoid Papulosis | 13.9% |
| 70 | Plasmablastic lymphoma | 13.9% |
| 71 | Astrocytoma | 13.5% |
| 72 | Ependymoma | 13.5% |
| 73 | oligodendroglioma | 13.5% |
| 74 | Ganglioglioma | 13.5% |
| 75 | gliosarcoma | 13.5% |
| 76 | Anaplastic astrocytoma | 13.5% |
| 77 | Anaplastic Oligodendroglioma | 13.5% |
| 78 | Cystadenocarcinoma | 13.5% |
| 79 | Fibrosarcoma | 13.5% |
| 80 | Osteosarcoma | 13.5% |
| 81 | Mucoepidermoid Carcinoma | 13.5% |
| 82 | Melanoma, Experimental | 13.3% |
| 83 | Adenoma | 13.3% |
| 84 | Ameloblastoma | 13.3% |
| 85 | Angiokeratoma | 13.3% |
| 86 | Carcinoma | 13.3% |
| 87 | Chordoma | 13.3% |
| 88 | Hemangioma | 13.3% |
| 89 | hemangiopericytoma | 13.3% |
| 90 | Lymphangioma | 13.3% |
| 91 | Mesenchymoma | 13.3% |
| 92 | Nevus | 13.3% |
| 93 | Teratoma | 13.3% |
| 94 | Hepatoblastoma | 13.3% |
| 95 | Mixed Tumor, Mullerian | 13.3% |
| 96 | Germinoma | 13.3% |
| 97 | Teratocarcinoma | 13.3% |
| 98 | Angiofibroma | 13.3% |
| 99 | Sarcoma | 13.3% |
| 100 | Epithelioma | 13.3% |
| 101 | Monoclonal Gammopathy of Undetermined Significance | 13.2% |
| 102 | Malignant Carcinoid Syndrome | 13% |
| 103 | Adenofibroma | 12.8% |
| 104 | Fibroadenoma | 12.8% |
| 105 | Malignant Fibrous Histiocytoma | 12.8% |
| 106 | Carcinoma, Ehrlich Tumor | 12.6% |
| 107 | Dermoid Cyst | 12.6% |
| 108 | Carcinoma, Lewis Lung | 12.6% |
| 109 | Glioblastoma | 12.5% |
| 110 | Neuroblastoma | 12.5% |
| 111 | Glioblastoma Multiforme | 12.5% |
| 112 | Hypergammaglobulinemia | 12.3% |
| 113 | Bowen's Disease | 12.2% |
| 114 | Paraganglioma | 12.2% |
| 115 | Rhabdomyosarcoma | 12.2% |
| 116 | Giant Cell Tumor of Bone | 12.2% |
| 117 | Trophoblastic Neoplasms | 12.2% |
| 118 | Leukemia, Experimental | 12.1% |
| 119 | Ganglioneuroblastoma | 12% |
| 120 | Autoimmune Diseases | 11.9% |
| 121 | Hamartoma | 11.9% |
| 122 | Hypersensitivity | 11.9% |
| 123 | Immunologic Deficiency Syndromes | 11.9% |
| 124 | Neoplasms, Hormone-Dependent | 11.9% |
| 125 | Neoplasms, Multiple Primary | 11.9% |
| 126 | Paraneoplastic Syndromes | 11.9% |
| 127 | Precancerous Conditions | 11.9% |
| 128 | Neoplasms, Second Primary | 11.9% |
| 129 | Immune reconstitution syndrome | 11.9% |
| 130 | Immune Reconstitution Inflammatory Syndrome | 11.9% |
| 131 | Dermatofibrosarcoma | 11.6% |
| 132 | Dermatofibrosarcoma Protuberans | 11.6% |
| 133 | Choriocarcinoma | 11.2% |
| 134 | Carcinoma, Lobular | 11.2% |
| 135 | Pheochromocytoma | 10.9% |
| 136 | Alveolar rhabdomyosarcoma | 10.9% |
| 137 | Burkitt Lymphoma | 10.8% |
| 138 | Leukemia L1210 | 10.7% |
| 139 | Leukemia P388 | 10.7% |
| 140 | Acanthoma | 10.7% |
| 141 | Endometrial Stromal Sarcoma | 10.5% |
| 142 | Carcinoid Heart Disease | 10.4% |
| 143 | Leukemia, Radiation-Induced | 10.2% |
| 144 | Sarcoma, Experimental | 10% |
| 145 | Neurofibrosarcoma | 10% |
| 146 | Thymoma | 9.9% |
| 147 | Malignant histiocytosis | 9.9% |
| 148 | Histiocytic sarcoma | 9.9% |
| 149 | Adenocarcinoma | 9.9% |
| 150 | Carcinoma in Situ | 9.9% |
| 151 | Carcinoma, Transitional Cell | 9.9% |
| 152 | Phyllodes Tumor | 9.9% |
| 153 | Dysgerminoma | 9.9% |
| 154 | Hemangioendothelioma | 9.9% |
| 155 | Lipoma | 9.9% |
| 156 | Myoma | 9.9% |
| 157 | Myxoma | 9.9% |
| 158 | Neuroma | 9.9% |
| 159 | Papilloma | 9.9% |
| 160 | Pseudomyxoma Peritonei | 9.9% |
| 161 | Retinoblastoma | 9.9% |
| 162 | Seminoma | 9.9% |
| 163 | Papillomatosis | 9.9% |
| 164 | Angiolipoma | 9.9% |
| 165 | Myelolipoma | 9.9% |
| 166 | Neoplasms, Bone Tissue | 9.9% |
| 167 | Neoplasms, Fibrous Tissue | 9.9% |
| 168 | Smooth Muscle Tumor | 9.9% |
| 169 | Adenomatosis, Pulmonary | 9.9% |
| 170 | Adenomatous Polyps | 9.9% |
| 171 | Carcinoma, Large Cell | 9.9% |
| 172 | Carcinoma, Small Cell | 9.9% |
| 173 | Desmoplastic Small Round Cell Tumor | 9.9% |
| 174 | Schnitzler Syndrome | 9.9% |
| 175 | Chondroma | 9.9% |
| 176 | Enchondroma | 9.9% |
| 177 | Sarcoma 180 | 9.5% |
| 178 | Cyst | 8.9% |
| 179 | Neoplastic Processes | 8.9% |
| 180 | Neoplastic Syndromes, Hereditary | 8.9% |
| 181 | Pregnancy Complications, Neoplastic | 8.9% |
| 182 | Transfusion Reaction | 8.9% |
| 183 | Hypotensive Transfusion Reaction | 8.9% |
| 184 | Neoplasms, Experimental | 8.8% |
| 185 | Mastocytosis | 8.7% |
| 186 | Mastocytosis, Systemic | 8.6% |
| 187 | Adenoid Cystic Carcinoma | 8.2% |
| 188 | fibroma | 8.2% |
| 189 | Fibromatosis | 8.2% |
| 190 | Osteoblastoma | 8.2% |
| 191 | Osteoma | 8.2% |
| 192 | Rhabdomyoma | 8.2% |
| 193 | Chondromatosis | 8.2% |
| 194 | Adenocarcinoma, Clear Cell | 8.2% |
| 195 | Cholangiocarcinoma | 8.2% |
| 196 | Cervical Intraepithelial Neoplasia | 8.2% |
| 197 | Hemangioblastoma | 8.2% |
| 198 | Lymphoma, Extranodal NK-T-Cell | 8.2% |
| 199 | Heavy Chain Disease | 7.9% |
| 200 | Multiple Endocrine Neoplasia | 7.8% |
| 201 | Acoustic Neuroma | 7.6% |
| 202 | Leukemia, Myelomonocytic, Chronic | 7.4% |
| 203 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 7.4% |
| 204 | Fibromatosis, Aggressive | 7.4% |
| 205 | Fibromatosis, Abdominal | 7.4% |
| 206 | Klatskin Tumor | 7.4% |
| 207 | Carcinoma, Pancreatic Ductal | 7.4% |
| 208 | Basal Cell Nevus Syndrome | 7% |
| 209 | Neoplasms, Radiation-Induced | 7% |
| 210 | Optic Nerve Glioma | 6.9% |
| 211 | Paraneoplastic Encephalomyelitis | 6.8% |
| 212 | Abdominal Neoplasms | 6.8% |
| 213 | Erythroplasia | 6.8% |
| 214 | Follicular cyst | 6.8% |
| 215 | Head and Neck Neoplasms | 6.8% |
| 216 | Hydatidiform Mole | 6.8% |
| 217 | Immune Complex Diseases | 6.8% |
| 218 | Mucocele | 6.8% |
| 219 | Pilonidal Cyst | 6.8% |
| 220 | Soft Tissue Neoplasms | 6.8% |
| 221 | Thoracic Neoplasms | 6.8% |
| 222 | Thyroglossal Cyst | 6.8% |
| 223 | Antiphospholipid Syndrome | 6.8% |
| 224 | Synovial Cyst | 6.8% |
| 225 | Latex allergy | 6.8% |
| 226 | Aberrant Crypt Foci | 6.8% |
| 227 | Glomerulonephritis, Membranoproliferative | 6.8% |
| 228 | Nephroblastoma | 6.7% |
| 229 | Mammary Neoplasms, Experimental | 6.7% |
| 230 | Vipoma | 6.6% |
| 231 | Cryoglobulinemia | 6.6% |
| 232 | POEMS Syndrome | 6.6% |
| 233 | Hepatocellular Adenoma | 6.6% |
| 234 | Mastocytoma | 6.2% |
| 235 | Leukemia, Myeloid, Chronic-Phase | 6.1% |
| 236 | Sturge-Weber Syndrome | 6% |
| 237 | Gastrointestinal Stromal Tumors | 6% |
| 238 | Hemangioma, Cavernous | 5.9% |
| 239 | Mesoblastic Nephroma | 5.9% |
| 240 | neurofibroma | 5.9% |
| 241 | Prolactinoma | 5.6% |
| 242 | Growth Hormone-Secreting Pituitary Adenoma | 5.6% |
| 243 | Tuberous Sclerosis | 5.5% |
| 244 | Digestive System Neoplasms | 5.4% |
| 245 | Endocrine Gland Neoplasms | 5.4% |
| 246 | Eye Neoplasms | 5.4% |
| 247 | Nervous System Neoplasms | 5.4% |
| 248 | Environmental Illness | 5.4% |
| 249 | Multiple Endocrine Neoplasia Type 1 | 5.2% |
| 250 | Bone neoplasms | 5.2% |
| 251 | Leukoplakia | 5.2% |
| 252 | Lupus Erythematosus, Systemic | 5.2% |
| 253 | Lymphocele | 5.2% |
| 254 | Pancreatic Cyst | 5.2% |
| 255 | Skin Neoplasms | 5.2% |
| 256 | Hematologic Neoplasms | 5.2% |
| 257 | Overlap syndrome | 5.2% |
| 258 | Addison Disease | 5.1% |
| 259 | Barrett Esophagus | 5.1% |
| 260 | Breast Cyst | 5.1% |
| 261 | Actinic keratosis | 5.1% |
| 262 | Mediastinal Cyst | 5.1% |
| 263 | Neoplasm Invasiveness | 5.1% |
| 264 | Neoplasm Metastasis | 5.1% |
| 265 | Neoplasm Recurrence, Local | 5.1% |
| 266 | Parovarian Cyst | 5.1% |
| 267 | Pemphigus | 5.1% |
| 268 | Pericardial Cyst | 5.1% |
| 269 | Splenic Neoplasms | 5.1% |
| 270 | Thymic Cyst | 5.1% |
| 271 | Carcinogenesis | 5.1% |
| 272 | Autoimmune thyroiditis | 5.1% |
| 273 | Myxoid cyst | 5.1% |
| 274 | Primary Adrenal Insufficiency | 5.1% |
| 275 | Metastasis | 5.1% |
| 276 | insulinoma | 5.1% |
| 277 | Lymphopenia | 5% |
| 278 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 5% |
| 279 | Autoimmune hepatitis | 5% |
| 280 | granulosa cell tumor | 4.9% |
| 281 | Carcinoma, Ovarian Epithelial | 4.9% |
| 282 | Thrombocytopenic purpura | 4.8% |
| 283 | Gastrinoma | 4.7% |
| 284 | Glucagonoma | 4.7% |
| 285 | Adenomatous Polyposis Coli | 4.7% |
| 286 | Adrenocortical carcinoma | 4.6% |
| 287 | Lambert-Eaton Myasthenic Syndrome | 4.6% |
| 288 | Parathyroid Neoplasms | 4.5% |
| 289 | Peritoneal Neoplasms | 4.5% |
| 290 | Thyroid Neoplasm | 4.5% |
| 291 | Thyroid carcinoma | 4.5% |
| 292 | Dupuytren Contracture | 4.5% |
| 293 | anaphylaxis | 4.4% |
| 294 | Food Allergy | 4.4% |
| 295 | Retroperitoneal Neoplasms | 4.4% |
| 296 | Anaphylactic shock | 4.4% |
| 297 | Urticaria Pigmentosa | 4.4% |
| 298 | Autoimmune thrombocytopenia | 4.4% |
| 299 | Immune thrombocytopenic purpura | 4.4% |
| 300 | Leydig Cell Tumor | 4.4% |
| 301 | Liver Neoplasms, Experimental | 4.3% |
| 302 | Latent Autoimmune Diabetes in Adults | 4.1% |
| 303 | Agammaglobulinemia | 4.1% |
| 304 | Dermatitis Herpetiformis | 4.1% |
| 305 | Kounis Syndrome | 4.1% |
| 306 | Nasopharyngeal carcinoma | 4.1% |
| 307 | Renal Cell Carcinoma | 4% |
| 308 | Papillary Renal Cell Carcinoma | 4% |
| 309 | HIV Infections | 4% |
| 310 | Transfusion-Related Acute Lung Injury | 4% |
| 311 | Corpus Luteum Cyst | 4% |
| 312 | Ovarian Cysts | 4% |
| 313 | Tracheal Neoplasms | 4% |
| 314 | Pancreatic Neoplasm | 3.9% |
| 315 | Carcinoma, Endometrioid | 3.9% |
| 316 | Leukoplakia, Oral | 3.9% |
| 317 | Paraneoplastic Cerebellar Degeneration | 3.8% |
| 318 | Serum Sickness | 3.8% |
| 319 | Asthma, Aspirin-Induced | 3.8% |
| 320 | Respiratory Hypersensitivity | 3.5% |
| 321 | Denys-Drash Syndrome | 3.5% |
| 322 | Rheumatoid Arthritis | 3.4% |
| 323 | Choledochal Cyst | 3.4% |
| 324 | Juvenile arthritis | 3.4% |
| 325 | Mouth Neoplasms | 3.4% |
| 326 | Sick Building Syndrome | 3.4% |
| 327 | Central Nervous System Neoplasms | 3.4% |
| 328 | Multiple Chemical Sensitivity | 3.4% |
| 329 | Vascular Neoplasms | 3.4% |
| 330 | Thymus Neoplasms | 3.4% |
| 331 | Graves Disease | 3.4% |
| 332 | Genital Neoplasms, Female | 3.3% |
| 333 | Pancreatic Pseudocyst | 3.3% |
| 334 | Urticaria | 3.3% |
| 335 | Vasculitis, Leukocytoclastic, Cutaneous | 3.3% |
| 336 | Peutz-Jeghers Syndrome | 3.3% |
| 337 | Esophageal Neoplasms | 3.3% |
| 338 | Anti-Glomerular Basement Membrane Disease | 3.3% |
| 339 | HTLV-I Infections | 3.3% |
| 340 | Lymphatic Metastasis | 3.3% |
| 341 | Neoplasms, Unknown Primary | 3.3% |
| 342 | Leukemic Infiltration | 3.3% |
| 343 | Breast Neoplasms, Male | 3.3% |
| 344 | Neoplasm Micrometastasis | 3.3% |
| 345 | Triple Negative Breast Neoplasms | 3.3% |
| 346 | Job Syndrome | 3.3% |
| 347 | Thyroid Nodule | 3.3% |
| 348 | Milk Allergy | 3.3% |
| 349 | Wheat Hypersensitivity | 3.3% |
| 350 | Myelitis, Transverse | 3.3% |
| 351 | Limbic Encephalitis | 3.3% |
| 352 | Testicular Neoplasms | 2.9% |
| 353 | Adrenal Gland Neoplasms | 2.7% |
| 354 | Gastrointestinal Neoplasms | 2.7% |
| 355 | Genital Neoplasms, Male | 2.7% |
| 356 | Liver neoplasms | 2.7% |
| 357 | Uveal Neoplasms | 2.7% |
| 358 | Myasthenia Gravis | 2.7% |
| 359 | Urologic Neoplasms | 2.7% |
| 360 | Uveomeningoencephalitic Syndrome | 2.7% |
| 361 | Drug Eruptions | 2.7% |
| 362 | Sebaceous Gland Neoplasms | 2.7% |
| 363 | Spinal Neoplasms | 2.7% |
| 364 | Bone Marrow Neoplasms | 2.7% |
| 365 | Chronic granulomatous disease | 2.6% |
| 366 | Granulomatosis with polyangiitis | 2.6% |
| 367 | Dermatitis, Allergic Contact | 2.6% |
| 368 | HIV Seropositivity | 2.6% |
| 369 | Polycystic Ovary Syndrome | 2.6% |
| 370 | Opsoclonus-Myoclonus Syndrome | 2.6% |
| 371 | Kernicterus | 2.5% |
| 372 | Meningeal Neoplasms | 2.5% |
| 373 | Myasthenia Gravis, Autoimmune, Experimental | 2.5% |
| 374 | Stiff-Person Syndrome | 2.3% |
| 375 | Nose Neoplasms | 2.3% |
| 376 | Polyradiculoneuropathy | 2.3% |
| 377 | Polyradiculoneuritis | 2.3% |
| 378 | Palatal Neoplasms | 2.3% |
| 379 | Ataxia Telangiectasia | 2.2% |
| 380 | Acquired Immunodeficiency Syndrome | 2.2% |
| 381 | AIDS related complex | 2.2% |
| 382 | Hydrops Fetalis | 2.2% |
| 383 | Felty Syndrome | 2.2% |
| 384 | Lupus Nephritis | 2.2% |
| 385 | Ear Neoplasms | 2% |
| 386 | Eyelid Neoplasms | 2% |
| 387 | Lung Neoplasms | 2% |
| 388 | Pleural Neoplasms | 2% |
| 389 | Meningeal Carcinomatosis | 2% |
| 390 | Xeroderma Pigmentosum | 2% |
| 391 | Pituitary Adenoma | 2% |
| 392 | Pituitary Neoplasms | 2% |
| 393 | Angioedema | 2% |
| 394 | Cell Transformation, Viral | 2% |
| 395 | Brain Neoplasms | 2% |
| 396 | Multiple Sclerosis | 2% |
| 397 | Salivary Gland Neoplasms | 2% |
| 398 | Spinal Cord Neoplasms | 2% |
| 399 | Tongue Neoplasms | 2% |
| 400 | Uterine Neoplasms | 2% |
| 401 | Vaginal Neoplasms | 2% |
| 402 | Vulvar Neoplasms | 2% |
| 403 | Uterine Cancer | 2% |
| 404 | Acute Generalized Exanthematous Pustulosis | 2% |
| 405 | Fallopian Tube Neoplasms | 2% |
| 406 | AIDS-Related Opportunistic Infections | 1.9% |
| 407 | Vasculitis, Central Nervous System | 1.9% |
| 408 | Dermatitis, Atopic | 1.9% |
| 409 | ovarian neoplasm | 1.9% |
| 410 | HIV Wasting Syndrome | 1.9% |
| 411 | Rheumatoid Vasculitis | 1.9% |
| 412 | AIDS Dementia Complex | 1.9% |
| 413 | AIDS-Associated Nephropathy | 1.9% |
| 414 | Neuromyelitis Optica | 1.8% |
| 415 | Leukoencephalitis, Acute Hemorrhagic | 1.8% |
| 416 | Lupus Vasculitis, Central Nervous System | 1.8% |
| 417 | Pharyngeal Neoplasms | 1.7% |
| 418 | Asthma | 1.7% |
| 419 | Central Nervous System Cysts | 1.7% |
| 420 | Bronchial Neoplasms | 1.7% |
| 421 | Bile Duct Neoplasms | 1.7% |
| 422 | gallbladder neoplasm | 1.7% |
| 423 | Intestinal Neoplasms | 1.7% |
| 424 | Penile Neoplasms | 1.7% |
| 425 | Prostatic Neoplasms | 1.7% |
| 426 | Stomach Neoplasms | 1.7% |
| 427 | Asthma, Exercise-Induced | 1.7% |
| 428 | Status Asthmaticus | 1.7% |
| 429 | Multiple Pulmonary Nodules | 1.7% |
| 430 | Wiskott-Aldrich Syndrome | 1.6% |
| 431 | Sicca Syndrome | 1.6% |
| 432 | Sjogren's Syndrome | 1.6% |
| 433 | Encephalomyelitis, Acute Disseminated | 1.6% |
| 434 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1.6% |
| 435 | Erythema Nodosum | 1.6% |
| 436 | Neuritis, Autoimmune, Experimental | 1.6% |
| 437 | Polycythemia Vera | 1.6% |
| 438 | Dermatitis, Photoallergic | 1.6% |
| 439 | HIV-Associated Lipodystrophy Syndrome | 1.6% |
| 440 | Supratentorial Neoplasms | 1.6% |
| 441 | Multiple Sclerosis, Chronic Progressive | 1.6% |
| 442 | Multiple Sclerosis, Relapsing-Remitting | 1.6% |
| 443 | Endometrial Neoplasms | 1.6% |
| 444 | Laryngeal neoplasm | 1.5% |
| 445 | Zollinger-Ellison syndrome | 1.5% |
| 446 | Hereditary Angioedema Type III | 1.5% |
| 447 | Hereditary Angioedema Types I and II | 1.5% |
| 448 | Brain Stem Neoplasms | 1.5% |
| 449 | Asthma, Occupational | 1.4% |
| 450 | Aspergillosis, Allergic Bronchopulmonary | 1.4% |
| 451 | Guillain-Barre Syndrome | 1.4% |
| 452 | Bladder Neoplasm | 1.4% |
| 453 | Kidney Neoplasm | 1.4% |
| 454 | Ureteral Neoplasms | 1.4% |
| 455 | Urethral Neoplasms | 1.4% |
| 456 | Farmer's Lung | 1.4% |
| 457 | Angioedemas, Hereditary | 1.4% |
| 458 | Hypopharyngeal Neoplasms | 1.4% |
| 459 | Pleural Effusion, Malignant | 1.4% |
| 460 | Hypopharyngeal Cancer | 1.4% |
| 461 | Choroid Plexus Papilloma | 1.4% |
| 462 | Hay fever | 1.4% |
| 463 | Rhinitis, Allergic, Perennial | 1.4% |
| 464 | Parotid Neoplasms | 1.4% |
| 465 | Prostatic Neoplasms, Castration-Resistant | 1.4% |
| 466 | Nelson Syndrome | 1.3% |
| 467 | Toxic Epidermal Necrolysis | 1.2% |
| 468 | Stevens-Johnson Syndrome | 1.2% |
| 469 | Tonsillar Neoplasms | 1.2% |
| 470 | Cerebellar Neoplasms | 1.2% |
| 471 | Cecal Neoplasms | 1.2% |
| 472 | Duodenal Neoplasms | 1.2% |
| 473 | Giant Cell Arteritis | 1.1% |
| 474 | Temporal Arteritis | 1.1% |
| 475 | Radicular Cyst | 1% |
| 476 | Nasopharyngeal Neoplasms | 1% |
| 477 | Appendiceal Neoplasms | 1% |
| 478 | Colonic Neoplasms | 1% |
| 479 | Rectal Neoplasms | 1% |
| 480 | Colorectal Neoplasms | 1% |
| 481 | Paranasal Sinus Neoplasms | 0.9% |
| 482 | Anus Neoplasms | 0.8% |
| 483 | Sigmoid Neoplasms | 0.8% |
| 484 | Miller Fisher Syndrome | 0.8% |
| 485 | Maxillary Sinus Neoplasms | 0.8% |